New Risk Stratification in Patients with Femoropopliteal PAD. Can We Fight Against the Poor Prognosis?

J Atheroscler Thromb · 2021 · PMC8592699 · PMID 33883346

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

incredibly significantno p-value reported

In that respect, it is incredibly significant that Tomoi et al. 4) showed that AF and the CHA2DS2-VASc scores are independent risk factors that increase major adverse cardiovascular events (MACE), but not major adverse limb event in Japanese patients with PAD who underwent endovascular treatment in the femoropopliteal (FP) region.

also in 125 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.